Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Relation of Contrast-Induced Nephropathy to Long-Term Mortality After Percutaneous Coronary Intervention

(2014) Mitsuru Abe et al.   AMERICAN JOURNAL OF CARDIOLOGY

Statins and Contrast-induced Acute Kidney Injury with Coronary Angiography

(2014) Sumeet Gandhi et al.   AMERICAN JOURNAL OF MEDICINE

The Prevention of Contrast-Induced Nephropathy

(2014) Trang H. Au et al.   ANNALS OF PHARMACOTHERAPY

Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow

(2014) Mustafa Gür et al.   ATHEROSCLEROSIS

No-Reflow Phenomenon

(2013) Gennaro Galasso et al.   ANGIOLOGY

Short-term statin therapy for prevention of contrast-induced AKI

(2013) Dimitri P. Mikhailidis et al.   Nature Reviews Nephrology

Association between glomerular filtration rate and endothelial function in an elderly community cohort

(2012) Elisabet Nerpin et al.   ATHEROSCLEROSIS

Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion

(2011) Nihat Sen et al.   ATHEROSCLEROSIS

Mild chronic kidney disease is an independent predictor of long-term mortality after emergency angiography and primary percutaneous intervention in patients with ST-elevation myocardial infarction

(2011) Niall G Campbell et al.   HEART

Impact of Chronic Pre-Treatment of Statins on the Level of Systemic Inflammation and Myocardial Perfusion in Patients Undergoing Primary Angioplasty

(2010) Vecih Oduncu et al.   AMERICAN JOURNAL OF CARDIOLOGY

No-Reflow Phenomenon Following Percutaneous Coronary Intervention for Acute Myocardial Infarction: Incidence, Outcome, and Effect of Pharmacologic Therapy

(2010) SHEREIF H. REZKALLA et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

(2010) Gjin Ndrepepa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of distal embolization on the timing of platelet and inflammatory cell activation in interventional coronary no-reflow

(2010) Thierry Charron et al.   THROMBOSIS RESEARCH

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

(2008) A. S. Astrup et al.   DIABETES CARE

The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: The role of inflammation

(2008) Turgay Celik et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction

(2007) G. L. Smith et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY